These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Radical resection of hilar bile duct carcinoma and predictors of survival. Todoroki T; Kawamoto T; Koike N; Takahashi H; Yoshida S; Kashiwagi H; Takada Y; Otsuka M; Fukao K Br J Surg; 2000 Mar; 87(3):306-13. PubMed ID: 10718799 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and surgical features of Klatskin tumors. Santoro E; Sacchi M; Carboni F; Santoro R; Scardamaglia F Chir Ital; 1999; 51(1):1-7. PubMed ID: 10514910 [TBL] [Abstract][Full Text] [Related]
6. The experiences of hilar skeletonization for the treatment of locally advanced proximal bile duct cancer. Kim MW; Kim WH; Wang HJ; Chung JB; Chun M Hepatogastroenterology; 2001; 48(41):1298-301. PubMed ID: 11677950 [TBL] [Abstract][Full Text] [Related]
7. Could a high resectability rate improve the long-term survival of patients with proximal bile duct cancer? Veroux M; Madia C; Fiamingo P; Caglià P; Valastro M; Amodeo C; Veroux P; Gagliano M; Basso S; D'Amico DF J Surg Oncol; 2006 Mar; 93(3):199-205. PubMed ID: 16482599 [TBL] [Abstract][Full Text] [Related]
8. Surgical treatment for carcinoma at the confluence of the major hepatic ducts. Iwasaki Y; Okamura T; Ozaki A; Todoroki T; Takase Y; Ohara K; Nishimura A; Otsu H Surg Gynecol Obstet; 1986 May; 162(5):457-64. PubMed ID: 3704902 [TBL] [Abstract][Full Text] [Related]
10. Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies--the question of long-term palliation. Bruha R; Petrtyl J; Kubecova M; Marecek Z; Dufek V; Urbanek P; Kodadova J; Chodounsky Z Hepatogastroenterology; 2001; 48(39):631-7. PubMed ID: 11462891 [TBL] [Abstract][Full Text] [Related]
11. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study. Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008 [TBL] [Abstract][Full Text] [Related]
12. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome. Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899 [TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of proximal bile duct tumors. Gazzaniga GM; Faggioni A; Filauro M Int Surg; 1985; 70(1):45-8. PubMed ID: 2410390 [TBL] [Abstract][Full Text] [Related]
14. Surgical treatment for proximal bile duct carcinoma. Kusano T; Tamai O; Miyazato H; Isa T; Shiraishi M; Muto Y; Furukawa M Int Surg; 1998; 83(2):119-23. PubMed ID: 9851327 [TBL] [Abstract][Full Text] [Related]
15. Surgical indication and significance of portal vein resection in biliary and pancreatic cancer. Tashiro S; Uchino R; Hiraoka T; Tsuji T; Kawamoto S; Saitoh N; Yamasaki K; Miyauchi Y Surgery; 1991 Apr; 109(4):481-7. PubMed ID: 1848949 [TBL] [Abstract][Full Text] [Related]
16. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Takamura A; Saito H; Kamada T; Hiramatsu K; Takeuchi S; Hasegawa M; Miyamoto N Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1357-65. PubMed ID: 14630274 [TBL] [Abstract][Full Text] [Related]
17. [Metallic mesh endoprosthesis and intraluminal high dose rate 192Ir brachytherapy in the palliative treatment of malignant bile duct obstruction. Initial results]. Pakisch B; Klein GE; Stücklschweiger G; Lammer J; Poier E; Leitner H; Poschauko J; Hausegger KA; Hackl A Rofo; 1992 Jun; 156(6):592-5. PubMed ID: 1377518 [TBL] [Abstract][Full Text] [Related]
18. Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas. Dvorák J; Jandík P; Melichar B; Jon B; Mergancová J; Zoul Z; Vacek Z; Petera J Hepatogastroenterology; 2002; 49(46):916-7. PubMed ID: 12143240 [TBL] [Abstract][Full Text] [Related]